Janssen Therap Company Profile
What is the competitive landscape for JANSSEN THERAP
JANSSEN THERAP has one approved drug.
There are two US patents protecting JANSSEN THERAP drugs.
Drugs and US Patents for Janssen Therap
International Patents for Janssen Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2006504658 | ⤷ Start Trial |
| Montenegro | 00131 | ⤷ Start Trial |
| South Africa | 200903907 | ⤷ Start Trial |
| Montenegro | P9208 | ⤷ Start Trial |
| Serbia | 20050058 | ⤷ Start Trial |
| Hong Kong | 1214513 | ⤷ Start Trial |
| Malaysia | 148844 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Janssen Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1527050 | 50/2014 | Austria | ⤷ Start Trial | PRODUCT NAME: BEDAQUILIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEURE- ODER BASENADDITIONSSALZ DAVON, EINSCHLIESSLICH BEDAQUILINFUMARAT; REGISTRATION NO/DATE: EU/1/13/901 20140307 |
| 1527050 | 92520 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: BEDAQUILINE, OU SON SEL D ADDITION D ACIDE OU DE BASE PHARMACEUTIQUEMENT ACCEPTABLE, Y COMPRIS LE FUMARATE DE BEDAQUILINE. FIRST REGISTRATION: 20140307 |
| 1527050 | 132014902288493 | Italy | ⤷ Start Trial | PRODUCT NAME: BEDAQUILINA O UN SUO SALE DI ADDIZIONE DI ACIDO O BASE FARMACEUTICAMENTE ACCETTABILE INCLUSO BEDAQUILINA FUMARATO(SIRTURO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/901, 20140305 |
| 1527050 | CA 2014 00044 | Denmark | ⤷ Start Trial | PRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE-ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305 |
| 1527050 | 2014/045 | Ireland | ⤷ Start Trial | PRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
| 1527050 | 122014000083 | Germany | ⤷ Start Trial | PRODUCT NAME: BEDAQUILIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEURE- ODER BASENADDITIONSSALZ DAVON; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
| 1527050 | SPC/GB14/057 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REGISTERED: UK EU/1/13/901 20140307 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

